CYP2C9 genotyping in acenocoumarol treatment: Is it a cost-effective addition to international normalized ratio monitoring?

T Schalekamp, GJJ Boink, Loes Visser, Bruno Stricker, A (Antonius) Boer, OH Klungel

Research output: Contribution to journalArticleAcademicpeer-review

36 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)511-520
Number of pages10
JournalClinical Pharmacology & Therapeutics
Volume79
Issue number6
Publication statusPublished - 2006

Cite this